| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 04/14/2004 | EP1406617A1 Diaminediols for the treatment of alzheimer's disease |
| 04/14/2004 | EP1180515B1 Benzoxazole compounds, process for the preparation thereof and herbicides |
| 04/14/2004 | EP1140072B1 Compounds and methods |
| 04/13/2004 | US6720452 Adamantane derivatives |
| 04/13/2004 | US6720424 Vegf (vascular endothelial growth factor) receptor antagonists and angiogenesis inhibitors suppress vascular hyperpermeability; phenylalkylcarbonyl substituent on the amino |
| 04/08/2004 | WO2003027064B1 Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical co mpositions containing the same |
| 04/08/2004 | US20040068013 Supplying in situ using amino acid; immobilization |
| 04/08/2004 | US20040067971 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/08/2004 | US20040067927 Substituted alkyldiamines |
| 04/08/2004 | US20040067912 Microbiocides, antibiotic, antitumor agent |
| 04/08/2004 | US20040067229 Azobenzene derivatives as labeling agents and intermediates thereof |
| 04/07/2004 | EP1404695A2 Universal supports for oligonucleotide synthesis |
| 04/07/2004 | EP1404652A1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 04/07/2004 | EP1404642A2 Synthesis and intermediates |
| 04/07/2004 | EP1404639A1 Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof |
| 04/07/2004 | EP1240132B1 Adamantane derivatives |
| 04/07/2004 | EP0910561B1 Inhibitors of oleamide hydrolase |
| 04/06/2004 | US6716881 Carbanilides used as pesticides |
| 04/06/2004 | US6716861 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent |
| 04/06/2004 | CA2190992C Naphthalene derivatives |
| 04/03/2004 | CA2453071A1 Genes and proteins for the production of polyene polyketides |
| 04/01/2004 | WO2004026810A1 Tricyclo[6.2.2]dodeca-2(7),3,5-trien-4-carbonyl)amino]-derivatives having rar-alpha- receptor selective biological activity |
| 04/01/2004 | WO2004026305A1 Diaryl ethers as opioid receptor antagonist |
| 04/01/2004 | WO2004026292A1 Antitussives |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | US20040063989 Preparation of at least one partial oxidation and/or ammoxidation product of propylene |
| 04/01/2004 | US20040063988 Preparation of at least one partial oxidation and/or ammoxidation product of propylene |
| 04/01/2004 | US20040063963 Dimerization; oxidation coupling of naphthol in presence of complex catalyst of copper chloride-tetramethylethylenediamine |
| 04/01/2004 | US20040063959 Esters and amides as PLA2 inhibitors |
| 04/01/2004 | US20040063786 Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical compositions containing the same |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063758 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate |
| 04/01/2004 | US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040062773 Compositions for the delivery of antigens |
| 03/31/2004 | EP1403247A1 N-Alkanoylphenylalanine derivatives |
| 03/31/2004 | EP1403235A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same |
| 03/31/2004 | EP1401801A1 Selective androgen receptor modulators and methods of use thereof |
| 03/31/2004 | CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same |
| 03/30/2004 | US6713510 Amide and ester derivatives |
| 03/25/2004 | WO2004024686A1 Biological low-molecular weight derivatives |
| 03/25/2004 | WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 03/25/2004 | WO2003076387A3 Process for preparing 2-aminoindan derivatives |
| 03/25/2004 | WO2003041728A8 Novel phenyl-propargylether derivatives |
| 03/25/2004 | US20040058904 Antiinflammatory agents; autoimmune disease |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | US20040057911 For protecting hair, skin and substrates such as polymers, textiles, fabrics, leathers and paints; cosmetics |
| 03/25/2004 | US20040057900 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 03/25/2004 | CA2499606A1 Biological low-molecular-weight derivatives |
| 03/25/2004 | CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | EP0784469B1 Compositions for the delivery of antigens |
| 03/24/2004 | CN1142988C Citric trialkyl amide surfactant |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/23/2004 | US6710205 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient |
| 03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 03/23/2004 | US6710073 Drugs that induce long term potentiation (ltp) and enhance cognitive function in mammals |
| 03/23/2004 | US6709642 Calixarene acetamido derivatives, preparation and use thereof for extracting strontium |
| 03/18/2004 | WO2004022775A1 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use |
| 03/18/2004 | WO2004022525A1 Amide derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2003099763A8 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 03/18/2004 | WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 03/18/2004 | WO2003018535A3 Novel aminobenzoephenones |
| 03/18/2004 | US20040054230 Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem |
| 03/18/2004 | US20040053907 Cell adhesion inhibitors |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | CA2497322A1 Urea-, glycerate- and , hydroxyamide-headed hydrocarbon chain lyotropic phase forming surfactants |
| 03/17/2004 | EP1397370A1 B-benzyloxyaspartate derivatives with amino group on benzene ring |
| 03/17/2004 | EP1397341A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 03/17/2004 | EP1242364B1 Adamantane derivatives |
| 03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
| 03/17/2004 | CN1141876C Phenoxypropionic acid N-alkyl-N-2-fluorophenyl amide compounds with herbicidal activity |
| 03/16/2004 | US6706916 Optically active amino acid derivatives and processes for the preparation of the same |
| 03/16/2004 | US6706763 Agonistic drug on human peroxisome proliferator-activated receptor (ppar) |
| 03/16/2004 | US6706664 Benzoxazole compounds, process for the preparation thereof and herbicides |
| 03/11/2004 | WO2004020398A1 Photostable cationic organic sunscreen compounds and compositions obtained therefrom |
| 03/11/2004 | WO2004020397A1 Standard compound for immunoassay for dioxin and method of immunoassay for dioxin |
| 03/11/2004 | WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators |
| 03/11/2004 | WO2003106380A3 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 03/11/2004 | WO2003088915A3 Novel sodium channel blockers |
| 03/11/2004 | US20040049075 Process for the production of calcium pantothenate |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040048928 Containing an amide or sulfonamide group; sunscreens for human skin and/or hair, as well as glass, plastic, textile, paint, varnish, or foodstuff. |
| 03/11/2004 | US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 03/11/2004 | US20040048856 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 03/11/2004 | US20040048797 Regulation of TNF-alpha |
| 03/11/2004 | US20040048777 Compounds and compositions for delivering active agents |
| 03/10/2004 | EP1395586A2 Method for the production of zolpidem |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395251A2 Aminediols as agents for the treatment of alzheimer's disease |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481355A Process for prepn. of acylphenylalanines |
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
| 03/09/2004 | US6703467 Adhesives and sealants |
| 03/09/2004 | US6703379 Benzene derivatives and pharmaceutical use thereof |
| 03/09/2004 | US6702705 Prodrugs activated by targeted catalytic proteins |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2004017920A2 Novel biphenyl and biphenyl-like cannabinoids |
| 03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |